Frontiers in Pharmacology | Respiratory Pharmacology

Original Research

Published on 11 Oct 2023

Hypoxia releases S-nitrosocysteine from carotid body glomus cells—relevance to expression of the hypoxic ventilatory response

in Respiratory Pharmacology

James M. Seckler
Paulina M. Getsy
Walter J. May
Benjamin Gaston
Santhosh M. Baby
Tristan H. J. Lewis
James N. Bates
Stephen J. Lewis

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1250154

1,933 views
4 citations

Original Research

Published on 03 Oct 2023

Exposure-response analyses of efzofitimod in patients with pulmonary sarcoidosis

in Respiratory Pharmacology

Gennyne Walker
Ryan Adams
Lauren Guy
Abhijeeth Chandrasekaran
Nelson Kinnersley
Pavithra Ramesh
Lu Zhang
Fran Brown
Vis Niranjan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1258236

3,642 views
4 citations

Original Research

Published on 21 Sep 2023

Qualitative and quantitative evaluation of computed tomography changes in adults with cystic fibrosis treated with elexacaftor-tezacaftor-ivacaftor: a retrospective observational study

in Respiratory Pharmacology

Sabine Dettmer
Oliver Weinheimer
Annette Sauer-Heilborn
Oliver Lammers
Mark O. Wielpütz
Jan Fuge
Tobias Welte
Frank Wacker
Felix C. Ringshausen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1245885

2,941 views
5 citations

Original Research

Published on 14 Sep 2023

Exploration of the mechanism of aloin ameliorates of combined allergic rhinitis and asthma syndrome based on network pharmacology and experimental validation

in Respiratory Pharmacology

Yan Feng
Han Qiao
Hongyun Liu
Jvfei Wang
Huaping Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218030

3,394 views
9 citations

Original Research

Published on 05 Sep 2023

Using extracellular matrix derived from sugen-chronic hypoxia lung tissue to study pulmonary arterial hypertension

in Respiratory Pharmacology

Patrick A. Link
Laszlo Farkas
Rebecca L. Heise

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192798

2,471 views
3 citations

Original Research

Published on 01 Sep 2023

Use of polymyxin B with different administration methods in the critically ill patients with ventilation associated pneumonia: a single-center experience

in Respiratory Pharmacology

Rupeng Shi
Yuanyuan Fu
Yujing Gan
Danying Wu
Suming Zhou
Min Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1222044

3,191 views
12 citations

Original Research

Published on 24 Aug 2023

Lomerizine attenuates LPS-induced acute lung injury by inhibiting the macrophage activation through reducing Ca2+ influx

in Respiratory Pharmacology

Yunduan Song
Yusen Gou
Jiameng Gao
Dongxin Chen
Haibo Zhang
Wenjuan Zhao
Feng Qian
Ajing Xu
Yao Shen

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1236469

3,577 views
4 citations

Original Research

Published on 23 Aug 2023

Obesity exacerbates influenza-induced respiratory disease via the arachidonic acid-p38 MAPK pathway

in Respiratory Pharmacology

Ravishankar Chandrasekaran
Carolyn R. Morris
Isabella M. Butzirus
Zoe F. Mark
Amit Kumar
Dhemerson Souza De Lima
Nirav Daphtary
Minara Aliyeva
Matthew E. Poynter
Vikas Anathy

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1248873

3,064 views
5 citations

Original Research

Published on 16 Aug 2023

A 20:1 synergetic mixture of cafedrine/theodrenaline accelerates particle transport velocity in murine tracheal epithelium via IP3 receptor-associated calcium release

in Respiratory Pharmacology

Götz Schmidt
Gerrit Rienas
Sabrina Müller
Fabian Edinger
Michael Sander
Christian Koch
Michael Henrich

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1155930

1,569 views
2 citations

Original Research

Published on 16 Aug 2023

Comparison of the clinical efficacy and toxicity of nebulized polymyxin monotherapy and combined intravenous and nebulized polymyxin for the treatment of ventilator-associated pneumonia caused by carbapenem-resistant gram-negative bacteria: a retrospective cohort study

in Respiratory Pharmacology

Zhenping Wu
Siying Zhang
Yelin Cao
Qiyu Wang
Keyuan Sun
Xia Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1209063

2,952 views
5 citations

Original Research

Published on 16 Aug 2023

Prognostic value of oxygen inhalation therapy for simple nocturnal hypoxemia in COPD: a meta-analysis

in Respiratory Pharmacology

Ling Sun
Ya-Fei Chang
Yun-Fei Wang
Xian-Zhong Ran
Xiang-Rong Li
Quan-Xin Xie
Bin Ning

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1123945

2,152 views

Editorial

Published on 15 Aug 2023

Editorial: Case reports in respiratory pharmacology 2022

in Respiratory Pharmacology

Przemyslaw Zdziarski
Luisa Ricciardi
Roberto Paganelli

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1242273

2,212 views
2 citations

Review

Published on 07 Aug 2023

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies

in Respiratory Pharmacology

Hehua Guo
Jiazheng Sun
Siyu Zhang
Yalan Nie
Sirui Zhou
Yulan Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1205948

12,955 views
23 citations

Review

Published on 03 Aug 2023

Molecular mechanisms of COVID-19-induced pulmonary fibrosis and epithelial-mesenchymal transition

in Respiratory Pharmacology

Peng Pi
Zhipeng Zeng
Liqing Zeng
Bing Han
Xizhe Bai
Shousheng Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1218059

6,239 views
15 citations

Clinical Trial

Published on 28 Jul 2023

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial

in Respiratory Pharmacology

Xiaobo Yang
Yun Tang
Ruofei Du
Yuan Yu
Jiqian Xu
Jiancheng Zhang
Hong Liu
Xiaojing Zou
Lehao Ren
Shiying Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1139872

3,748 views
2 citations

Correction

Published on 26 Jul 2023

Corrigendum: Host factor interaction networks identified by integrative bioinformatics analysis reveals therapeutic implications in COPD patients with COVID-19

in Respiratory Pharmacology

Wenjiang Zheng
Ting Wang
Peng Wu
Qian Yan
Chengxin Liu
Hui Wu
Shaofeng Zhan
Xiaohong Liu
Yong Jiang
Hongfa Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1256022

1,324 views